Fundraising Fox

Clarus Ventures

Venture capital

Menlo Park · Pre-Seed–Late Stage · 8 people tracked

Find your way into Clarus Ventures

449 people in our graph share verified history with the Clarus Ventures team — schools, employers, funds. One of them is your warm intro.

Crystal Huangunlockedknows Michele Park · together at New Enterprise Associates (NEA) (overlapped)
×4knows the team · via Credit Suisse
×5knows the team · via New Enterprise Associates (NEA)
×2knows the team · via Piper Jaffray
Fox Verdict
Sign up to see your fit

Investment thesis

Clarus Ventures is a life sciences investment firm, now part of Blackstone Life Sciences (BXLS), that funds drug development, including late-stage Phase III programs. Based in Menlo Park, California, its team has been involved in bringing numerous medicines to market across pharmaceutical and biotechnology companies.

Stage
Pre-Seed–Late Stage
HQ
Menlo Park, CA, US
Instruments
Equity
Founded
2005
Tracked investments
7

Team · 8 people

from public directories
Dennis Henner· General Partner
Kurt C. Wheeler· General Partner
Nicholas Galakatos· General Partner
Nicholas J. Simon· General Partner
Robert W. Liptak· General Partner
Scott Requadt· General Partner

What they invest in

from 7 of 7 portfolio companies

Biotech ×5Healthtech ×5

HQs:United States×6

Investments · 7 tracked

founders shown can be your intro path

By year:2016 · 12012 · 12 dated

Cleave Biosciencescleavetherapeutics.com

BiotechBurlingame, US

Mark Rolfe(Executive Officer)Laura Shawver(Executive Officer, Director)Timothy Smith(Executive Officer)

BoardAlfred Scheidegger(Director)inPeter Thompson(Director)Carol Gallagher(Director)

Co-investorsAstellas Venture Management LLCNew Enterprise Associates (NEA)Nextech Invest5AM VenturesOrbiMedOsage University Partners+1 more

FerroKin BiosciencesinFeb 2012acquired by Shire

Developed a next-generation iron chelator for iron overload in transfusion-dependent anemia; acquired by Shire in 2012.

BiotechSan Carlos, US

Hugh Y. Rienhoff, Jr., M.D.(Executive Officer, Director)in

BoardMarten Steen(Director)Dennis Henner, Ph.D.(Director)Bryant E. Fong(Director)

Co-investorsMC Healthcare Ventures

Flowonix Medical

HealthtechMt Olive, US

Louis Altieri(Executive Officer)Larry Heaton(Executive Officer)in

BoardSteven C. Adler(Director)David Jenkins(Director)Kurt Wheeler(Director)Donald P. Carson(Director)

Co-investorsClarus

Imagoimagobio.comin𝕏

A pharmaceutical company that develops medicines and vaccines, with research pipelines and clinical trials aimed at new treatments.

BiotechHealthtech

Co-investorsHighlight CapitalAmgen VenturesFrazier Healthcare Partners

Imago BioSciences, Inc.

HealthtechSan Carlos, US

Hugh Y. Rienhoff(Executive Officer, Director)inLaura G. Eichorn(Executive Officer)in

BoardPatrick Heron(Director)inDennis Henner(Director)Alan Sachs(Director)

Co-investorsAmgen VenturesFrazier Healthcare PartnersFrazier Life Sciences

Lumos Pharmalumos-pharma.comin𝕏Apr 2016

Lumos Pharma is a clinical-stage biopharmaceutical company developing therapies for rare diseases, with a lead candidate targeting Pediatric Growth Hormone Deficiency.

BiotechHealthtechAustin, US

Richard John Hawkins(Executive Officer, Director)John C. McKew(President and Chief Scientific Officer)inPisit "Duke" Pitukcheewanont(Chief Medical Officer)inLori Lawley(Chief Financial Officer)inBrad Powers(Chief Compliance Officer and General Counsel)inCampbell Murray(Executive Chairman)in

Co-investorsNew Enterprise Associates (NEA)Deerfield Management CompanySante Health VenturesSante VenturesWellcome Trust

VBI Vaccinesvbivaccines.comin𝕏Defunct

VBI Vaccines is a biopharmaceutical company developing vaccine candidates using virus-like particle (VLP) platforms, including proprietary enveloped VLP and mRNA-launched eVLP technologies.

BiotechHealthtechCambridge, US

Marc Kirchmeier(Vice President, Formulation Development)Egidio Nascimento(Chief Financial Officer)inDavid Anderson(Senior Vice President, Research)inJeff Baxter(President and Chief Executive Officer)inAdam T. Buckley(Vice President, Business Development)inMurray G. Smith(Executive Officer)

Co-investors5AM VenturesARCH Venture PartnersK2 HealthVentures

Exits · 1

IPOs and acquisitions across the tracked portfolio

FerroKin Biosciencesacq. by Shire

Portfolio news

latest coverage across their companies
Funding & Growth - Imago Systems, Inc.

Imago · imagosystems.com · Sep 4, 2025

Frequently asked questions

What stage does Clarus Ventures invest at?
Clarus Ventures invests at the Pre-Seed, Seed, Series A, Series B, Series C, Late Stage stages.
What sectors does Clarus Ventures focus on?
Clarus Ventures focuses on AI & Machine Learning, Biotech, Consumer, Crypto & Web3, Fintech, LegalTech, Logistics & Supply Chain, Media & Entertainment, SaaS, Social, Travel & Hospitality.
Where is Clarus Ventures located?
Clarus Ventures is headquartered in Menlo Park, US.

Co-investors · 5

New Enterprise Associates (NEA)

New Enterprise Associates (NEA) is a venture capital firm that invests in and provides long-term support to founders building new companies.

$200K – $40M
Sanofi Ventures

Sanofi Ventures is the corporate venture capital arm of Sanofi, investing in early-stage biotech and digital health companies focused on improving human health. It serves as Sanofi's entry point into the innovation ecosystem.

$5M
Novartis Venture Fund

The Novartis Venture Fund invests in innovative life science companies, focusing on biotechnology and biopharmaceuticals at various stages of growth, aiming to drive patient benefit and generate returns.

$5M – $25M
Lightstone Ventures

Lightstone Ventures is a life sciences venture firm founded in 2012 that invests in biotech and medtech companies, backing founders translating scientific breakthroughs into therapies and medical technologies.

Pontifax Venture Capital

Pontifax is an investment firm focused on life sciences and healthcare technologies, backing companies across all development stages from early research to clinical-stage growth.

$6.3M – $128M

Firms observed investing alongside Clarus Ventures, from public investor directories. Shared companies are the overlap with Clarus Ventures's recorded portfolio.

Similar investors

Featured in lists